RuCu Nanosheets with Ultrahigh Nanozyme Activity for Chemodynamic Therapy.

Yang, Jian; Fang, Le; Jiang, Ruibin; Qi, Lubin; Xiao, Yating; Wang, Wenxi; Ismail, Ismail; Fang, Xiaohong · Adv Healthc Mater · 2023

basic_science · Level V

Where this comes from

Abstract

Nanoenzymes have been widely explored for chemodynamic therapy (CDT) in cancer treatment. However, poor catalytic efficiency of nanoenzymes, especially in the tumor microenvironment with insufficient H<sub>2</sub> O<sub>2</sub> and mild acidity, limits the effect of CDT. Herein, a new ultrathin RuCu nanosheet (NS) based nanoenzyme which has a large specific surface area and abundant channels and defects is developed. The RuCu NSs show superb catalytic efficiency for the oxidation of peroxidase substrate H<sub>2</sub> O<sub>2</sub> at a wide range of pH and their catalytic efficiency (k<sub>cat</sub> /K<sub>m</sub> = 177.2 m<sup>-1</sup>  s<sup>-1</sup> ) is about 14.9 times higher than that of the single-atom catalyst FeN<sub>3</sub> P. Besides being an efficient nanozyme as peroxidase, the RuCu NSs possess other two enzyme activities, not only disproportionating superoxide anion to produce H<sub>2</sub> O<sub>2</sub> but also consuming glutathione to keep a high concentration of H<sub>2</sub> O<sub>2</sub> in the tumor microenvironment for Fenton reaction. With these advantages, the RuCu NSs exhibit good performance to kill cancer cells and inhibit tumor growth in mice, demonstrating a promising potential as new CDT reagent.

Medical subject headings